IPO - Nova Minerals Ltd

Form Type: F-1

Filing Date: 2025-07-03

Corporate Action: Ipo

Type: New

Accession Number: 000164117225017729

Filing Summary: Nova Minerals Limited is offering 1,200,000 American Depositary Shares (ADSs), representing 72,000,000 ordinary shares, in a firm commitment public offering as part of its registration statement filed under the Securities Act of 1933. Each ADS corresponds to 60 ordinary shares, held by The Bank of New York Mellon as the depositary. The ADSs will be listed on The Nasdaq Capital Market under the symbol 'NVA'. The assumed public offering price is US$12.56, based on the last reported sale price as of June 30, 2025, with the final price to be determined in negotiations with underwriters. The registration statement includes provisions for continuous or delayed offerings and confirms the company's status as an emerging growth company under applicable regulations. This preliminary prospectus is subject to change and the offering cannot proceed until the SEC declares the registration statement effective.

Form Type: DRS

Filing Date: 2025-05-22

Corporate Action: Ipo

Type: New

Accession Number: 000164117225012020

Filing Summary: Nova Minerals Limited is filing a Registration Statement on Form F-1 on May 22, 2025, in connection with a public offering of American Depositary Shares (ADSs) representing ordinary shares of the company. Each ADS represents 60 ordinary shares and is planned to be listed on The Nasdaq Capital Market under the symbol 'NVA'. The company is in the exploration stage for its Estelle Gold and Critical Minerals Project located in Alaska, intending to become a significant player in the gold and strategic minerals market. The offering aims to not only secure funding but also to fast-track potential commercial production of antimony and gold, with expectations for their first gold pour in 2027. The company has reported a combined S-K 1300 compliant resource of 5.17 million ounces of gold at the Estelle Project, of which 4.41 million ounces is attributable to Nova. The prospectus warns investors of the high degree of risk associated with their investment and contains forward-looking statements regarding the company's development plans and timelines, with a caution that actual results may differ materially from expected outcomes.